BlueWillow Biologics



BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan, an...

Ali I. Fattom
SVP, Vaccine Research & Development
Bob Nissen
Business Development Consultant
Fiona Cameron
Regulatory Consultant
Frances Kivel
Clinical Operations Consultant
Frank J. Malinoski
Clinical Consultant
Shyamala Ganesan
Principal Scientist & Program Manager
Susan Ciotti
VP & Head of Formulations
Tarek Hamouda
Senior Director, Clinical Research

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.